Cargando…

Clinical Aspects and Management of Levodopa-Induced Dyskinesia

In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa do...

Descripción completa

Detalles Bibliográficos
Autores principales: Tambasco, Nicola, Simoni, Simone, Marsili, Erica, Sacchini, Elisa, Murasecco, Donatella, Cardaioli, Gabriela, Rossi, Aroldo, Calabresi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372050/
https://www.ncbi.nlm.nih.gov/pubmed/22701811
http://dx.doi.org/10.1155/2012/745947
_version_ 1782235315622117376
author Tambasco, Nicola
Simoni, Simone
Marsili, Erica
Sacchini, Elisa
Murasecco, Donatella
Cardaioli, Gabriela
Rossi, Aroldo
Calabresi, Paolo
author_facet Tambasco, Nicola
Simoni, Simone
Marsili, Erica
Sacchini, Elisa
Murasecco, Donatella
Cardaioli, Gabriela
Rossi, Aroldo
Calabresi, Paolo
author_sort Tambasco, Nicola
collection PubMed
description In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa dosing or the early use of dopamine agonists. Dopamine agonists with different pharmacological profile are available. Our paper was aimed to analyse the clinical impact and the management of dyskinesias with dopamine agonists.
format Online
Article
Text
id pubmed-3372050
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33720502012-06-14 Clinical Aspects and Management of Levodopa-Induced Dyskinesia Tambasco, Nicola Simoni, Simone Marsili, Erica Sacchini, Elisa Murasecco, Donatella Cardaioli, Gabriela Rossi, Aroldo Calabresi, Paolo Parkinsons Dis Review Article In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa dosing or the early use of dopamine agonists. Dopamine agonists with different pharmacological profile are available. Our paper was aimed to analyse the clinical impact and the management of dyskinesias with dopamine agonists. Hindawi Publishing Corporation 2012 2012-06-03 /pmc/articles/PMC3372050/ /pubmed/22701811 http://dx.doi.org/10.1155/2012/745947 Text en Copyright © 2012 Nicola Tambasco et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Tambasco, Nicola
Simoni, Simone
Marsili, Erica
Sacchini, Elisa
Murasecco, Donatella
Cardaioli, Gabriela
Rossi, Aroldo
Calabresi, Paolo
Clinical Aspects and Management of Levodopa-Induced Dyskinesia
title Clinical Aspects and Management of Levodopa-Induced Dyskinesia
title_full Clinical Aspects and Management of Levodopa-Induced Dyskinesia
title_fullStr Clinical Aspects and Management of Levodopa-Induced Dyskinesia
title_full_unstemmed Clinical Aspects and Management of Levodopa-Induced Dyskinesia
title_short Clinical Aspects and Management of Levodopa-Induced Dyskinesia
title_sort clinical aspects and management of levodopa-induced dyskinesia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372050/
https://www.ncbi.nlm.nih.gov/pubmed/22701811
http://dx.doi.org/10.1155/2012/745947
work_keys_str_mv AT tambasconicola clinicalaspectsandmanagementoflevodopainduceddyskinesia
AT simonisimone clinicalaspectsandmanagementoflevodopainduceddyskinesia
AT marsilierica clinicalaspectsandmanagementoflevodopainduceddyskinesia
AT sacchinielisa clinicalaspectsandmanagementoflevodopainduceddyskinesia
AT muraseccodonatella clinicalaspectsandmanagementoflevodopainduceddyskinesia
AT cardaioligabriela clinicalaspectsandmanagementoflevodopainduceddyskinesia
AT rossiaroldo clinicalaspectsandmanagementoflevodopainduceddyskinesia
AT calabresipaolo clinicalaspectsandmanagementoflevodopainduceddyskinesia